Biotia

About

Biotia is a health-tech company based in New York that specializes in genomics and AI-driven solutions for infectious disease detection and diagnostics. Founded as a spinout from the Jacobs Technion-Cornell Institute at Cornell Tech, Biotia operates a CLIA-certified lab in collaboration with SUNY Downstate Health Sciences University. The company is dedicated to improving health outcomes, particularly in underserved regions, by building a comprehensive microbial reference library and utilizing advanced diagnostics. Biotia offers several innovative products. For researchers, GeoSeeq is an AI-driven platform that aids in outbreak detection and pandemic prevention by integrating climate and health data. BIOTIA-DX is a metagenomics tool that provides higher sensitivity for identifying pathogens compared to traditional methods. For clinicians, BIOTIA-ID is a genomics-based diagnostic assay designed for immunocompromised patients, while BIOTIA-ID URINE is a urine-specific assay that enhances the detection of pathogens in urinary infections. Biotia collaborates with various hospitals, research institutions, and global health organizations to further its mission.